Investor FAQs
Quantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company’s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live.
Quantum-Si is incorporated in Delaware.
Quantum-Si’s corporate headquarters are located at 29 Business Park Drive, Branford, CT 06405.
Quantum-Si common stock trades on the Nasdaq Stock Exchange under the ticker QSI.
Quantum-Si’s CUSIP number is 74765K105.
Quantum-Si’s auditor is PricewaterhouseCoopers.
Quantum-Si’s transfer agent is Continental Stock transfer & Trust Company. They can be reached by phone at (212) 509-4000 or by email at cstmail@continentalstock.com.
Shares of Quantum-Si can be purchased through the broker of your choice.
Quantum-Si’s fiscal year end is December 31.
To review Quantum-Si’s corporate governance policies, please visit the Corporate Governance section of the website.
Quarterly and annual reports and other investor materials are available under the SEC Filings section of the website. Additionally, all SEC filings can also be viewed directly on the SEC website.
Quantum-Si will issue a press release that includes the date of our next quarterly earnings call. These releases will be posted on the News section of our website, including the details for accessing the conference call and/or webcast to discuss the results.
If you wish to contact Quantum-Si’s investor relations team, please send an email to ir@quantum-si.com.
To automatically receive financial information by email, please visit the Email Alerts section of this website.
Please visit the Events section of the Investor Website.